APH vs. DOCS

Last updated Apr 2, 2026

Compare and contrast key facts about Amphenol Corporation (APH) and Doximity, Inc. (DOCS).

Performance

APH vs. DOCS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amphenol Corporation (APH) and Doximity, Inc. (DOCS). The values are adjusted to include any dividend payments, if applicable.

APH vs. DOCS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
APH Amphenol Corporation	-5.32%	96.08%	41.30%	31.85%	-11.96%	29.10%
DOCS Doximity, Inc.	-48.22%	-17.06%	90.41%	-16.45%	-33.05%	-5.42%

Fundamentals

Market Cap APH : $164.57B DOCS : $4.57B
EPS APH : $3.34 DOCS : $1.19
PE Ratio APH : 38.28 DOCS : 19.19
PEG Ratio APH : 1.27 DOCS : 0.12
PS Ratio APH : 7.08 DOCS : 7.20
PB Ratio APH : 12.27 DOCS : 4.66
Total Revenue (TTM) APH : $23.09B DOCS : $637.78M
Gross Profit (TTM) APH : $8.52B DOCS : $572.39M
EBITDA (TTM) APH : $6.89B DOCS : $268.45M

Returns By Period

In the year-to-date period, APH achieves a -5.32% return, which is significantly higher than DOCS's -48.22% return.

APH

• 1D: 1.07%
• 1M: -5.33%
• YTD: -5.32%
• 6M: 2.84%
• 1Y: 94.65%
• 3Y*: 47.44%
• 5Y*: 31.94%
• 10Y*: 25.43%

DOCS

• 1D: -1.59%
• 1M: -10.78%
• YTD: -48.22%
• 6M: -67.54%
• 1Y: -59.57%
• 3Y*: -10.87%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

APH vs. DOCS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APH

APH Risk / Return Rank: 90
APH Sharpe Ratio Rank: 93
APH Sortino Ratio Rank: 88
APH Omega Ratio Rank: 90
APH Calmar Ratio Rank: 87
APH Martin Ratio Rank: 91

DOCS

DOCS Risk / Return Rank: 4
DOCS Sharpe Ratio Rank: 2
DOCS Sortino Ratio Rank: 2
DOCS Omega Ratio Rank: 3
DOCS Calmar Ratio Rank: 8
DOCS Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

APH vs. DOCS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphenol Corporation (APH) and Doximity, Inc. (DOCS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	APH	DOCS	Difference
Sharpe ratio Return per unit of total volatility	2.32	-1.21	+3.53
Sortino ratio Return per unit of downside risk	2.66	-1.96	+4.61
Omega ratio Gain probability vs. loss probability	1.40	0.74	+0.66
Calmar ratio Return relative to maximum drawdown	3.41	-0.87	+4.28
Martin ratio Return relative to average drawdown	11.77	-1.82	+13.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

APH vs. DOCS - Sharpe Ratio Comparison

The current APH Sharpe Ratio is 2.32, which is higher than the DOCS Sharpe Ratio of -1.21. The chart below compares the historical Sharpe Ratios of APH and DOCS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	APH	DOCS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.32	-1.21	+3.53
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.09	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.94	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.62	-0.24	+0.86

Correlation

The correlation between APH and DOCS is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

APH vs. DOCS - Dividend Comparison

APH's dividend yield for the trailing twelve months is around 0.65%, while DOCS has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
APH Amphenol Corporation	0.65%	0.55%	0.79%	1.07%	1.06%	0.89%	0.80%	0.89%	1.09%	0.80%	0.86%	1.01%
DOCS Doximity, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

APH vs. DOCS - Drawdown Comparison

The maximum APH drawdown since its inception was -63.41%, smaller than the maximum DOCS drawdown of -80.53%. Use the drawdown chart below to compare losses from any high point for APH and DOCS.

Drawdown Indicators

	APH	DOCS	Difference
Max Drawdown Largest peak-to-trough decline	-63.41%	-80.53%	+17.12%
Max Drawdown (1Y) Largest decline over 1 year	-28.19%	-69.48%	+41.29%
Max Drawdown (5Y) Largest decline over 5 years	-28.73%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-37.56%	—	—
Current Drawdown Current decline from peak	-23.04%	-77.52%	+54.48%
Average Drawdown Average peak-to-trough decline	-13.55%	-56.36%	+42.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.16%	33.31%	-25.15%

Volatility

APH vs. DOCS - Volatility Comparison

Amphenol Corporation (APH) has a higher volatility of 13.75% compared to Doximity, Inc. (DOCS) at 6.88%. This indicates that APH's price experiences larger fluctuations and is considered to be riskier than DOCS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	APH	DOCS	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.75%	6.88%	+6.87%
Volatility (6M) Calculated over the trailing 6-month period	33.93%	37.68%	-3.75%
Volatility (1Y) Calculated over the trailing 1-year period	41.07%	49.33%	-8.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	29.46%	68.74%	-39.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.16%	68.74%	-41.58%

Financials

APH vs. DOCS - Profitability Comparison

The chart below illustrates the profitability comparison between Amphenol Corporation and Doximity, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

APH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Amphenol Corporation reported a gross profit of 2.46B and revenue of 6.44B. Therefore, the gross margin over that period was 38.2%.

DOCS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Doximity, Inc. reported a gross profit of 166.35M and revenue of 185.05M. Therefore, the gross margin over that period was 89.9%.

APH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Amphenol Corporation reported an operating income of 1.77B and revenue of 6.44B, resulting in an operating margin of 27.5%.

DOCS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Doximity, Inc. reported an operating income of 71.90M and revenue of 185.05M, resulting in an operating margin of 38.9%.

APH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Amphenol Corporation reported a net income of 1.20B and revenue of 6.44B, resulting in a net margin of 18.6%.

DOCS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Doximity, Inc. reported a net income of 61.56M and revenue of 185.05M, resulting in a net margin of 33.3%.